Evaluation of the efficacy and safety of propranolol, timolol maleate, and the combination of the two, in the treatment of superficial infantile haemangiomas.
暂无分享,去创建一个
Xukai Wang | Da-peng Xu | He Gong | Chen Cheng | Gang Li | Yue-xiao Li
[1] Lei Xue,et al. Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients. , 2013, The British journal of oral & maxillofacial surgery.
[2] Xiao-dong Chen,et al. [Topical timolol in the treatment of periocular superficial infantile hemangiomas: a prospective study]. , 2012, Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery.
[3] C. Price,et al. Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. , 2011, Archives of dermatology.
[4] C. Gorst,et al. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas. , 2011, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[5] C. Shields. Topical Treatment for Capillary Hemangioma of the Eyelid Using β-Blocker Solution , 2011 .
[6] P. Hoeger,et al. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action , 2010, The British journal of dermatology.
[7] E. Pope,et al. Topical timolol gel for infantile hemangiomas: a pilot study. , 2010, Archives of dermatology.
[8] Suqin Guo,et al. Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution. , 2010, Archives of ophthalmology.
[9] S. Friedlander,et al. Twenty years' experience of steroids in infantile hemangioma—a developing country's perspective , 2010 .
[10] Jia-wei Zheng,et al. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety]. , 2009, Zhonghua yi xue za zhi.
[11] A. Gangopadhyay,et al. Twenty years' experience of steroids in infantile hemangioma--a developing country's perspective. , 2009, Journal of pediatric surgery.
[12] Wang Xu-ka. The management of vascular anomalies , 2009 .
[13] I. Casteels,et al. The safety and efficacy of glaucoma medication in the pediatric population. , 2009, Journal of pediatric ophthalmology and strabismus.
[14] F. Boralevi,et al. Propranolol for severe hemangiomas of infancy. , 2008, The New England journal of medicine.
[15] R. Marcucio,et al. Patterns of Infantile Hemangiomas: New Clues to Hemangioma Pathogenesis and Embryonic Facial Development , 2006, Pediatrics.
[16] M. Mihm,et al. Current knowledge of the pathogenesis of infantile hemangiomas. , 2005, Archives of facial plastic surgery.
[17] D. Ribatti. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review , 2005, British journal of haematology.
[18] I. Frieden,et al. Hemangiomas of infancy. , 2003, Journal of the American Academy of Dermatology.
[19] E. Yeong,et al. Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: a review of 155 cases. , 2000, Journal of pediatric surgery.
[20] J. Mulliken,et al. Complications of systemic corticosteroid therapy for problematic hemangioma. , 1999, Plastic and reconstructive surgery.
[21] B. Achauer,et al. Management of hemangioma of infancy: review of 245 patients. , 1997, Plastic and reconstructive surgery.